Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Head & Neck 5Lymphoid 4Other hematologic neoplasm 3Genitourinary 2Breast 2Thoracic 1Sarcoma 1Other neoplasm 1CNS 1

Conditions

Brain Neoplasms 1905Glioblastoma 1797Glioma 1130Central Nervous System Neoplasms 599Astrocytoma 594Neuroblastoma 552Gliosarcoma 465Oligodendroglioma 364Neoplasms 312Breast Neoplasms 273Medulloblastoma 272Carcinoma, Non-Small-Cell Lung 227Recurrence 199Sarcoma 184Neoplasm Metastasis 183Melanoma 182Meningioma 177Ependymoma 176Lung Neoplasms 157Lymphoma 134Osteosarcoma 127Meningeal Carcinomatosis 126Neurofibromatosis 1 114Wilms Tumor 111Ovarian Neoplasms 110Diffuse Intrinsic Pontine Glioma 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Rhabdomyosarcoma 101Lymphoma, Non-Hodgkin 96Burkitt Lymphoma 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Wounds and Injuries × CNS × Clear all
NCT03839914 2026-04-29

Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients

The University of Hong Kong

Phase NA Active not recruiting
76 enrolled
CNS

Spinal Cord Neoplasms, Surgical Wound Infection, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡